Lucy Therapeutics

Lucy Therapeutics is a privately held biotech company founded in 2017 by Dr. Amy Ripka. Headquartered in Waltham, MA, the company is focused on developing novel mitochondrial-based therapies and diagnostic biomarkers for complex diseases. Their mission is to unravel the role of mitochondrial dysfunction in disease, with a particular focus on central nervous system disorders. Lucy Therapeutics is driven by the belief that understanding mitochondrial function can lead to new ways to diagnose and treat these conditions, ultimately changing the course of disease progression.

The company is named after the 3.2-million-year-old hominid fossil Lucy, as a tribute to the matrilineal inheritance of mitochondria. Lucy Therapeutics embraces a unique approach to drug discovery, seeking solutions from diverse perspectives and exploring the interconnected pathways involving mitochondria to identify key targets for disease disruption. Their lead program targets Parkinson's disease, with additional programs focused on Rett syndrome and other undisclosed targets. Lucy Therapeutics is committed to fostering an inclusive and equitable culture, where creativity and collaboration are valued.

Lucy Therapeutics does not explicitly state the job flexibility offered in its postings.

Lucy Therapeutics is a female-founded biotech company focused on developing mitochondrial-based therapies and diagnostic biomarkers for complex diseases. They are driven by a relentless curiosity about the role mitochondria play in diseases, particularly in the central nervous system, and aim to develop treatments that can slow or stop the progression of these illnesses by targeting the underlying mechanisms of mitochondrial dysfunction. Their mission is to change the course of mitochondrial-involved diseases so that diagnosis marks the beginning of a cure, rather than a point of no return.

Lucy Therapeutics fosters a culture that values relentless curiosity, creativity, and flexibility. They encourage their diverse team to pursue solutions from all angles and embrace an inclusive, equitable, and compassionate work environment. This approach allows them to achieve exceptional results while nurturing a collaborative and inquisitive atmosphere.

Lucy Therapeutics fosters an inclusive, equitable, and compassionate culture that values diversity of expertise and perspectives. They believe that a diverse team, ranging from basic science to business, allows them to approach challenges from all angles and achieve exceptional results in their mission to develop mitochondrial-based therapies.